Wire Stories
-
439Fabrinet Announces First Quarter Fiscal Year 2023 Financial Results
Record First Quarter Revenue of $655.4 Million Exceeds Guidance Record GAAP and Non-GAAP Net Income per Share Exceeds Guidance BANGKOK, Thailand–(BUSINESS WIRE)–Fabrinet...
-
487GOOD Meat and Singapore Put Cultivated Meat on COP27 Menu
New version of cultivated chicken launches at U.N. climate summit ALAMEDA, Calif.–(BUSINESS WIRE)–#COP27—GOOD Meat, the cultivated meat division of food technology company...
-
424National Geographic Documentary Films and Picturehouse Announce Release Dates and Debut Trailer and Key Art for Matthew Heineman�s RETROGRADE
From Oscar�-Nominated and Emmy�-Winning Director Matthew Heineman Comes a Gripping Documentary Capturing the Final Months of America�s War in Afghanistan In Theaters...
-
466Mauna Kea Technologies and Tasly Pharmaceutical Announce the Incorporation of Joint Venture in China
Tasly Mauna Kea Medical Engineering Technology Co. Ltd will expand reach of Cellvizio in China and launch a dedicated platform for neurosurgical...
-
407Global Microarray Market Report 2022: Rise in the Usage of Microarrays in Various Applications Drives Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Microarray Market (2022-2027) by Product & Service, Type, Application, End-Users, and Geography, Competitive Analysis and the Impact of Covid-19...
-
417Orano and the Japanese Utility TEPCO Enter a Stronger Phase of Cooperation for Small Scale Retrieval Planning Project from the Fukushima-Daiichi Plant
PARIS–(BUSINESS WIRE)–Regulatory News: Orano has signed an engineering support contract with TEPCO and its subsidiary FDEC1 responsible for the decommissioning of Fukushima,...
-
479EdiGene Biotechnology Moves into New R&D Center at Waltham, Mass. to Advance Proprietary LEAPER� Technology into Transformative in vivo RNA Editing Therapies
BEIJING & WALTHAM, Mass.–(BUSINESS WIRE)–EdiGene, Inc., a global, clinical-stage company focused on translating its gene-editing technologies into transformative genetic medicines for patients...
-
482MaaT Pharma Announces Participation in Scientific and Investor Conferences in November
LYON, France–(BUSINESS WIRE)–$MAAT–Regulatory News: MaaT Pharma (EURONEXT: MAAT � the �Company�), a French clinical-stage biotech and a pioneer in the development of...
-
416Vicat: Nine-month 2022 Sales
� L�ISLE D�ABEAU, France–(BUSINESS WIRE)–Regulatory News: Vicat (Paris:VCT): Consolidated sales of �2,697 million in the nine months to 30 September 2022, up...
-
373Global Biosimulation Technology Market Report 2022: Featuring 3DS BIOVIA, Advanced Chemistry Development, Certara USA, Genedata and Schrodinger Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Biosimulation Technology: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global market for Biosimulation Technology estimated...
